Evidence map›Paper›PMID 31737214›Full record

ArticleAmerican journal of translational research2019

LINC00994 promoted invasion and proliferation of gastric cancer cell via regulating miR-765-3p.

Ling Yuan, Tingting Ma, Wenjing Liu, Yan Chen, Qihui Yuan, Mengyi Ye, Lei Yu, Jiaxin Li, Yang Niu, Yi Nan

Open access · greenAbstract read
In one paragraph

Article in American journal of translational research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.8field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. CD45ROTheranostics · 2021
    Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Ling YuanPharmacy College of Ningxia Medical University Yinchuan 750004, China.
Tingting MaPharmacy College of Ningxia Medical University Yinchuan 750004, China.
Wenjing LiuTraditional Chinese Medicine College of Ningxia Medical University Yinchuan 750004, China.
Yan ChenTraditional Chinese Medicine College of Ningxia Medical University Yinchuan 750004, China.
Qihui YuanTraditional Chinese Medicine College of Ningxia Medical University Yinchuan 750004, China.
Mengyi YeTraditional Chinese Medicine College of Ningxia Medical University Yinchuan 750004, China.
Lei YuDepartment of Infectious Disease, The Fourth Hospital of Harbin Medical University Harbin 150001, Heilongjiang, China.
Jiaxin LiPharmacy College of Ningxia Medical University Yinchuan 750004, China.
Yang NiuNingxia Medical University Key Laboratory of Hui Ethnic Medicine Modernization Ministry of Education Yinchuan 750004, China.
Yi NanNingxia Medical University Key Laboratory of Hui Ethnic Medicine Modernization Ministry of Education Yinchuan 750004, China.
Ningxia Medical University · CNHarbin Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Emerging studies indicated that lncRNA is one crucial regulator in development and tumorigenesis. We firstly showed that LINC00994 was overexpressed in GC cells compare with GES-1. Compared to adjacent samples, the LINC00994 expression was increased in GC tissues by qRT-PCR assay. Furthermore, Elevated expression of LINC00994 induced GC cell invasion, proliferation and cycle. Luciferase reporter analysis indicated that ectopic miR-765-3p expression suppressed wild type LINC00994 luciferase activity, but not mutant LINC00994 in GC cells. Elevated expression of LINC00994 inhibited the miR-765-3p expression in GC cells. Compared to adjacent samples, the miR-765-3p expression was decreased in GC tissues by qRT-PCR assay. LINC00994 induced GC cell invasion and growth via modulating miR-765-3p. Thus, our data suggested an oncogenic role of LINC00994 in development of GC.

Indexed as

gastric cancerLINC00994lncRNAsmiR-765-3p

Identifiers

PMID31737214
PMCPMC6834511
OpenAlexW2990608468

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.